South Korea
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research
Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping. Lunit's presentations this year will highl...
November 08, 2022 | News
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being develop...
November 07, 2022 | News
Samyang Holdings' Lafullen Makes Splash in Korean Medical Aesthetics Market
- Successfully demonstrated Lafullen's safety and efficacy at autumn medical symposiums - Shared treatment protocols and clinical cases to lecturers by sp...
November 01, 2022 | News
Polyplus and ENcell sign MOU for gene therapy discovery and optimization projects in Korea
“ENCell is working to accelerate viral vector CMO business via a collaboration with Polyplus.”, said Dr. Jong Wook Chang, CEO of ENCell. &ldquo...
October 28, 2022 | News
Lunit Joins World Economic Forum Global Innovators Community
Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-only group of the world's most promising start-ups and scale-...
October 27, 2022 | News
Samsung Biologics Reports Third Quarter 2022 Financial Results
Recorded consolidated revenue of KRW 873 billion in Q3'22 Recorded consolidated operating profit of KRW 324.7 billion in Q3'...
October 27, 2022 | News
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available...
October 26, 2022 | News
SK bioscience Appoints New Executives towards Global Business Growth
Global experts continue to join SK bioscience, while its U.S. corporate entity is being established Company plans to strategically invest in personnel, ...
October 24, 2022 | News
Samsung Biologics obtains three global ISO certifications
Receives accreditation for information security management system, information security in cloud services, and anti-bribery management systems F...
October 14, 2022 | News
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000...
October 12, 2022 | News
수많은 제약 제조 조직이 보다 민첩하고 효율적이고 경쟁력을 갖추기 위해 차세대 모범 사례를 채택하고 있습니다.
Click Here To Know More 업계 동향을 최신 상태로 유지하고 가치 사슬에서 장기적인 ...
October 10, 2022 | News
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™
Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...
September 30, 2022 | News
GC Labs obtain certification of CDC standardization programs (VDSCP & HoSt)
GC Labs, a leading South Korea clinical laboratory, today announced that it has recently obtained certification of standardization prog...
September 29, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
